Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 24 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2002Which substitution pharmacotherapy is most effective in treating opioid dependence?Gowing, L.; Ali, R.; White, J.
2007Pharmacogenetics of opioidsSomogyi, A.; Barratt, D.; Coller, J.
2009Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulationDegenhardt, L.; Larance, B.; Bell, J.; Winstock, A.; Lintzeris, N.; Ali, R.; Scheuer, N.; Mattick, R.
2004CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomesHutchinson, M.; Menelaou, A.; Foster, D.; Coller, J.; Somogyi, A.
2006Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioidsMorrish, G.; Foster, D.; Somogyi, A.
2007Lack of influence of CYP2D6 genotype on the clearance of (R)- (S)- and racemic-methadonColler, J.; Joergensen, C.; Foster, D.; James, H.; Gillis, D.; Christrup, L.; Somogyi, A.
2020Data resource profile: the Opioid Agonist Treatment and Safety (OATS) Study, New South Wales, AustraliaLarney, S.; Jones, N.; Fiellin, D.A.; Nielsen, S.; Hickman, M.; Dobbins, T.; Murphy, T.; Ali, R.; Degenhardt, L.
2015Opioid-induced central immune signaling: implications for opioid analgesiaGrace, P.M.; Maier, S.F.; Watkins, L.R.
2005Short-term outcomes of five heroin detoxification methods in the Australian NEPOD projectDigiusto, E.; Lintzeris, N.; Breen, C.; Kimber, J.; Mattick, R.; Bell, J.; Ali, R.; Saunders, J.
2008Antinociceptive effects of high dose remifentanil in male methadone-maintained patientsHay, J.; White, J.; Bochner, F.; Somogyi, A.